Oncotarget (a primarily oncology-focused, peer-reviewed, open access journal) aims to maximize research impact through insightful peer-review; eliminate borders between specialties by linking different fields of oncology, cancer research and biomedical sciences; and foster application of basic and clinical science.
Its scope is unique. The term "oncotarget" encompasses all molecules, pathways, cellular functions, cell types, and even tissues that can be viewed as targets relevant to cancer as well as other diseases. The term was introduced in the inaugural Editorial,
Introducing Oncotarget.
As of January 1, 2022, Oncotarget has shifted to a continuous publishing model. Papers will now be published continuously within yearly volumes in their final and complete form and then quickly released to Pubmed.
Publication Alerts
Subscribe to receive alerts once a paper has been published by Oncotarget.
Viveka Nand Yadav, Daniel Zamler, Gregory J. Baker, Padma Kadiyala, Anat Erdreich-Epstein, Ana C. DeCarvalho, Tom Mikkelsen, Maria G. Castro, Pedro R. Lowenstein
Published Nov 11, 2016 · Vol. 7, No. 50 · pp. 83701-83719
Patrycja Czerwińska, Parantu K. Shah, Katarzyna Tomczak, Marta Klimczak, Sylwia Mazurek, Barbara Sozańska, Przemysław Biecek, Konstanty Korskis, Violetta Filas, Andrzej Mackiewicz, Jannik N. Andersen, Maciej Wiznerowicz
Published Nov 10, 2016 · Vol. 8, No. 1 · pp. 863-882
Lindsay C. Spender, G. John Ferguson, Sijia Liu, Chao Cui, Maria Romina Girotti, Gary Sibbet, Ellen B. Higgs, Morven K. Shuttleworth, Tom Hamilton, Paul Lorigan, Michael Weller, David F. Vincent, Owen J. Sansom, Margaret Frame, Peter ten Dijke, Richard Marais, Gareth J. Inman
Published Nov 9, 2016 · Vol. 7, No. 50 · pp. 81995-82012
